JCOGの基本情報 > 研究実績 > 頭頸部がんグループ

JCOGの基本情報頭頸部がんグループ

更新日:2014年9月16日

  1. 論文
    1. 委員会承認の治療研究
      K Nakamura, M Tahara, N Kiyota, et al.: Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706). Jpn J Clin Oncol. 39:460-463, 2009.
      F Kunieda , N Kiyota , M Tahara, et al.: Randomized Phase II/III Trial of Post-operative Chemoradiotherapy Comparing 3-Weekly Cisplatin with Weekly Cisplatin in High-risk Patients with Squamous Cell Carcinoma of Head and Neck: Japan Clinical Oncology Group Study (JCOG1008). Jpn J Clin Oncol. 44(8): 770-774, 2014.
    2. グループ代表者管理の治療研究
      M Fujii, K Tomita, W Nishijima, et al.: Phase I/II study of S-1 plus ciaplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer. Jpn J Clin Oncol. 40: 214-221, 2010.
      M Tahara, H Minami, M Kawashima, et al.: Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Cancer Sci. 102(2): 419-424, 2011.
      M Tahara, K Araki, S Okano, et al.: Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer. Ann Oncol. 22(1): 175-180, 2011.
      N Kiyota, M Tahara, S Okano, et al.: Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 42 (10): 927-933, 2012.
      S Kano, A Homma, R Hayashi, et al.: Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy. Int J Clin Oncol. E-pub 2012.
      S Kano, A Homma, R Hayashi, et al.: Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy. Oncology 84(5) 290-298, 2013.
      S Kano , R Hayashi, A Homma, et al.: Effect of local extension sites on survival in locally advanced maxillary sinus cancer. Head Neck. Aug 2013. [Epub ahead of print]
      A Homma, R Hayashi, K Matsuura, et al.: Lymph Node Metastasis in T4 Maxillary Sinus Squamous Cell Carcinoma: Incidence and Treatment Outcome. Ann Surg Oncol. 21(5):1706-1710, 2014.
      T Hama, Y Tokumaru, M Fujii, et al.: Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology. 87(3): 173-182, 2014.
      T Sakashita, A Homma, R Hayashi, et al.: The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomas. Oral Oncol. 50(7): 657-661, 2014.
      S Zenda, K Matsuura, H Tachibana, et al.: Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiother Oncol. 101(3): 410-414, 2011.
      S Zenda, S Ishii , M Kawashima, et al.: A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study. Int J Clin Oncol. 18(2): 350-355, 2013.
    3. 附随研究等
      なし
    4. 総説・解説
      藤井正人:頭頸部癌に対する薬物療法の進歩 日本耳鼻咽喉科学会会報116, 767-778, 2013.
  2. 主な学会発表
    1. 委員会承認の治療研究
      M Tahara, N Kiyota, J Mizusawa, et al.: Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN): results of the Japan Clinical Oncology Group study, JCOG 0706. 48th Annual meeting of the American Society of Clinical Oncology. Proc Am Soc Clin Oncol.30: abstr 5542, Jun 2012.
    2. グループ代表者管理の治療研究
      なし
    3. 附随研究等
      なし
    4. 総説・解説
      なし
トップへ戻る